Elimination of local macrophages in intestine prevents chronic colitis in interleukin-10-deficient mice

Digestive Diseases and Sciences

Volumn 48, Issue 2, 2003, Pages 408-414

  Watanabe, Norihiko ^a   Ikuta, Koichi ^a   Okazaki, Kazuichi ^a   Nakase, Hiroshi ^a   Tabata, Yasuhiko ^b   Matsuura, Minoru ^a   Tamaki, Hiroyuki ^a   Kawanami, Chiharu ^a   Honjo, Tasuku ^a   Chiba, Tsutomu ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Dichloromethylene diphosphonate; Drug delivery system; Inflammatory bowel disease; Interleukin 10; Macrophage; Microsphere

Indexed keywords

CLODRONIC ACID; INTERLEUKIN 10; LACTIC ACID; MICROSPHERE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL FUNCTION; COLITIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; ENTERITIS; LYMPH FOLLICLE; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; BIOPSY, NEEDLE; CHRONIC DISEASE; CLODRONIC ACID; COLITIS; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; MACROPHAGES; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; MICROSPHERES; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 0037326647     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021960401290     Document Type: Article

References (40)

1. MacDermott RP, Stenson WF: Alterations of the immune system in ulcerative colitis and Crohn's disease. Adv Immunol 42:285-328, 1988
2. Podolsky DK: Inflammatory bowel disease (1). N Engl J Med 325:928-937, 1991
3. Sartor RB: Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 92:5s-11s, 1997
4. Strober W, Ludviksson BR, Fuss IJ: The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease. Ann Intern Med 128:848-856, 1998
5. Blumberg RS, Saubermann LJ, Strober W: Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 11:648-656, 1999
6. + T cells. J Exp Med 178:237-244, 1993
7. + T cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice. Int Immunol 5:1461-1471, 1993
8. Neurath MF, Fuss IJ, Kelsall BL, Stuber E, Strober W: Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 182:1281-1290, 1995
9. Kuhn R, Lohler J, Rennick DM, Rajewsky K, Muller W: Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263-274, 1993
10. + T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med 184:241-251, 1996
11. Davidson NJ, Hudak SA, Lesley RE, Menon S, Leach MW, Rennick DM: IL-12, but not IFN-γ, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J Immunol 161:3143-3149, 1998
12. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, Chan SH: Kobayashi M, Young D, Nickbarg E: Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 176:1387-1398, 1992
13. + T cells. J Immunol 154:5071-5079, 1995
14. Berg DJ, Davidson N, Kuhn R, Muller W, Menon S, Holland G, Thompson Snipes L, Leach MW, Rennick D: Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 98:1010-1020, 1996
15. Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, Strober W: Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nat Med 2:998-1004, 1996
16. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, Maitland M, Norgard MV, Plevy SE, Smale ST, Brennan PJ, Bloom BR Godowski PJ, Modlin RL: Host defense mechanisms triggered by microbial lipopoteins through toll-like receptors. Science 285:732-736, 1999
17. Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, Bassetti M, Aderem A: The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401:811-815, 1999
18. Sellon RK, Tonkonogy S, Scbultz M, Dieleman LA, Grenther W, Balisb E, Rennick DM, Sartor RB: Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 66:5224-5231, 1998
19. Tabata Y, Ikada Y: Macrophage phagocytosis of biodegradable microspberes composed of L-lactic acid/glycolic acid homo- and copolymers. J Biomed Mater Res 22:837-858, 1988
20. Tabata Y, Inoue Y, Ikada Y. Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres. Vaccine 14:1677-1685, 1996
21. Nakase H, Okazaki K, Tabata Y, Uose S, Ohana M, Uchida K, Matsushima Y, Kawanami C, Oshima C, Ikada Y, Chiba T: Development of an oral drug delivery system targeting immune-regulating cells in experimental inflammatory bowel disease: a new therapeutic strategy. J Pharmacol Exp Ther 292:15-21, 2000
22. Nakase H, Okazaki K, Tabata Y, Uose, S. Ohana M, Uchida K, Nishi T, Debreceni A, Itoh T, Kawanami C, Iwano M, Ikada Y, Chiba T: An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis. J Pharmacol Exp Ther 297:1122-1128,2001
23. Jun HS, Yoon CS, Zbytnuik L, van Rooijen N, Yoon JW: The role of macropbages in T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Exp Med 189:347-358, 1999
24. Tran EH, Hoekstra K, van Rooijen N, Dijkstra CD, Owens R: Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol 161:3767-3775, 1998
25. Tabata Y, Ikada Y: Phagocytosis of polymer microspheres by macrophages. Adv Polymer Sci 94:107-141, 1990
26. Watanabe N, Nomura T, Takai T, Chiba T, Honjo R, Tsubata T: Antigen receptor cross-linking by anti-immunoglobulin antibodies coupled to cell surface membrane induces rapid apoptosis of normal spleen B cells. Scand J Immunol 47:541-547, 1998
27. Fuss IJ, Marth T, Neurath MF, Pearlstein GR, Jain A, Strober W: Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology 117:1078-1088, 1999
28. Watanabe N, Ikuta K, Fagarasan S, Yazumi S, Chiba T, Honjo T: Migration and differentiation of autoreactive B-1 cells induced by activated γ/δ T cells in antierythrocyte immunoglobulin transgenic mice. J Exp Med 192:1577-1586, 2000
29. Naito M, Nagai H, Kawano S, Umezu, H. Zhu H, Moriyama H, Yamamoto T, Takatsuka H, Takei Y: Liposome-encapsulated dichloromethylene diphosphonate induces macrophage apoptosis in vivo and in vitro. J Leukoc Biol 60:337-344, 1996
30. Nakase H, Okazaki K, Tabata Y, Ozeki M, Watanabe N, Ohana M, Uose S, Uchida K, Nishi T, Mastuura M, Tamaki H, Itoh T, Kawanami C, Chiba T: New cytokine delivery system using gelatin microspheres ontaining interleukin-10 for experimental inflammatory bowel disease. J Pharmacol Exp Ther 301:59-65, 2002
31. Allison MC, Cornwall S, Poulter LW, Dhillon AP, Pounder RE: Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease. Gut 29:1531-1538, 1988
32. Grimm MC, Pullman WE, Bennett GM, Sullivan PJ, Pavli P, Doe WF: Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa. J Gastroenterol 10:387-395, 1995
33. Mahida, YR. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm Bowel Dis 6:21-33, 2000
34. + population of monocytes in inflammatory bowel disease mucosa - implications for pathogenesis. Clin Exp Immunol 100:291-297, 1995
35. Rogler G, Hausmann M, Vogl D, Aschenbrenner E, Andus T, Falk W, Andreesen R, Scholmerich J, Gross V: Isolation and phenotypic characterization of colonic macrophages. Clin Exp Immunol 112:205-215, 1998
36. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent Puig P, Gower Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599-603, 2001
37. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411:603-606, 2001
38. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJ, Bridger S, van Deventer S, Forbes A, Nikolaus S, Lennard Jones JE, Foelsch UR, Krawczak M, Lewis C, Schreiber S, Mathew CG: Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357:1925-1928, 2001
39. Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Forster I, Akira S: Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10:39-49, 1999
40. Whitehead R: Pathology of Crohn's disease. In Inflammatory Bowel Disease, 2nd ed. JB Kirsner, RG Shorter (eds). Philadelphia, Lea & Febiger, 1980, pp 296-307